Metabolic alterations as a driver of chronicity in lung disease
Symposium Chairs: P. Hiemstra (Leiden, Netherlands), S. Meiners (München, Germany)
Aims: to provide an overview of metabolic reprogramming and to enhance understanding of the Warburg effect; to summarise evidence of aberrant metabolic reprogramming in lung cancer and immune cells and to outline therapeutic approaches that target aberrant metabolic changes in chronic lung diseases